Table 2.
Overview of assessments
| T0 (baseline) | Tmid (4 weeks) | T1 (3 months) | T2 (6 months) | T3 (9 months) | T4 (12 months) | T5 (15 months) | ||
|---|---|---|---|---|---|---|---|---|
| Primary outcome | ||||||||
| IDS-C | Depressive symptoms | x | x | x | x | x | x | |
| Secondary outcomes | ||||||||
| YMRS | (Hypo)manic symptoms | x | x | x | x | x | x | |
| SCID-I | Relapse | x | x | x | x | x | x | |
| ASRM | (Hypo)manic symptoms | x | ||||||
| QIDS-SR | Depressive symptoms | x | ||||||
| STAI | Anxiety symptoms | x | x | x | x | x | x | |
| FAST | Overall functioning | x | x | x | x | x | x | |
| MHC-SF | Positive mental health | x | x | x | x | x | x | x |
| FFMQ | Mindfulness | x | x | x | x | x | x | x |
| SCS-SF | Self-compassion | x | x | x | x | x | x | x |
| RPA-NL | Responses to positive affect | x | x | x | x | x | x | x |
| RRS-EXT | Brooding | x | x | x | x | x | x | x |
| Cost-effectiveness | ||||||||
| EQ-5D-5L | Quality of life and quality adjusted life years | x | x | x | x | x | x | |
| TiC-P | Costs associated with illness | x | x | x | x | x | x | |